Skip to Main Content

Paper Details

A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia.
Cancer Med
41
2016
AML, AML cells, Acute myeloid leukemia (AML, Acute myeloid leukemia (AML) cells, Tigecycline, acute myeloid leukemia, human, human AML cells, patients, tigecycline
Author NameAffiliation
John T SchillerDavid Geffen School of Medicine at university of california los angeles
Suman KambhampatiUniversity of Kansas Cancer Center
Martin S TallmanMemorial Sloan Kettering Cancer Center
Marcela GrondaPrincess Margaret Cancer Centre, University Health Network
Rose HurrenPrincess Margaret Cancer Centre, University Health Network
Aaron D SchimmerPrincess Margaret Cancer Centre, University Health Network
  • 1 - 6

Datasets

Release 1.2